Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases

Komiyama, Maki; Hasegawa, Koji

doi:10.15420/ecr.2021.10

Cited by 10 publications

(11 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several physiological changes, associated with psychological distress during the pandemic, can predispose patients to or worsen cardiovascular disease including increased oxidative stress, catecholamine, cortisol levels, aggregation of platelet, inflammatory cells, endothelial dysfunction, and stimulation of the sympathetic nervous system [ 47 , 48 ]. Anxiety and fear are psychological disorders that can coexist with heart failure and other cardiovascular diseases, and are even considered major risk factors for cardiovascular disease such as coronary artery disease, stress-cardiomyopathy, arrhythmias, stress-cardiomyopathy, myocarditis, cardiogenic shock, and cardiac arrest [ 48 , 49 ].…”

Section: Discussionmentioning

confidence: 99%

“…In conclusion, the serious impact of the pandemic on patients living with COPD or any other pre-existing chronic conditions can rationalize their fear and anxiety. Regular assessment of the patients’ psychological status related to COVID-19, and careful management of pre-existing chronic diseases should be considered as a main component of heart failure management [ 47 ] to assist with the stratification of risks for severe illness [ 59 ]. Thus, frontline health care providers should use reliable media such as governmental television channels and COVID-19 emergency hotlines and valid screening tools to assess the effect of COVID-19 on psychological status such as the anxiety scale [ 74 , 75 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study

Alkouri

Khader²,

Hweidi³

et al. 2022

JCM

View full text Add to dashboard Cite

Although the current management of COVID-19 is mainly focused on efficacious vaccine and infection control, the most common psychological reactions (such as fear and anxiety) associated with the COVID-19 pandemic have not been investigated and even neglected in patients with heart failure who are at greater risk for morbidity and mortality. We assessed COVID-19 related fear and anxiety among patients with heart failure and determined their associated factors. A cross sectional survey was conducted among 300 consecutive patients with heart failure during the period of March 2021–June 2021. Almost 50.7% of patients had fear of COVID-19 and 36.3% had coronavirus anxiety. Age > 55 was significantly associated with increased odds of fear (OR = 2.6) and anxiety (OR = 4.3). Patients with angina were more likely to have fear (OR = 3.0) and anxiety (OR = 2.2) and patients with chronic lung disease were more likely to have fear (OR = 3.0) and anxiety (OR = 3.3). Increased age, having angina, and having chronic lung disease were associated with increased odds of fear of COVID-19 and coronavirus anxiety. Psychological support needs to be integrated in patient care with special attention to physiological risk factors that are associated with COVID-19 comorbidities.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study

Alkouri

Khader²,

Hweidi³

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…Studies have shown that COVID-19 can lead to overwhelming stress, addiction to tobacco, alcohol, or increased obesity. "COVID-19 related depression" reflects the condition (58). Pressure from the coronavirus can lead to stress cardiomyopathy or an increased risk of heart failure (59).…”

Section: Analysis Of Reference Co-citationmentioning

confidence: 99%

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021

You

Shou

Fan

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

The aim of this study was to gain insight into the progress and dynamics of psycho-cardiological disease research and track its hot spots. We have analyzed psycho-cardiological disease-related literature extracted from the Web of Science (WOS) Core Collection from 2001 to 2021 with the help of Cite Space. As a result, we have included 5,032 records. Then, we have analyzed connected networks for the country, author, subject category, keywords, and cited reference. We have summarized the findings in four aspects. First, the annual quantitative distribution of publications is on the rise, although there is a slight drop. Second, in terms of country analysis, the United States, England, Australia, Germany, and Italy are the main research forces in psycho-cardiological diseases. At the same time, several academic entities represented by Andrew Steptoe and Roland von Känel, MD, have been formed based on the early consciousness of physical and mental health in these countries. Besides, China is also more concerned about it due to the rapid population aging process and the largest population. Third, the psycho-cardiological disease is multidisciplinary, including psychology, psychiatry, clinical medicine, such as cardiovascular system and neurology, public environmental and occupational health, and pharmacology. Finally, the results of keyword analysis and co-cited references indicate the hot spots and frontiers in psycho-cardiological disease. The hot spots in psycho-cardiological disease include three aspects. The first aspect includes psychosocial factors, such as depression, lack of social support, and low economic and social status; the second aspect includes priority populations, such as Alzheimer’s disease dementia caregivers, elderly, and patients with cancer, and the third aspect includes interventions, such as exercise therapy and diet. In addition, there are three future research frontiers. The first is a psycho-cardiological disease in patients with COVID-19; the second is cardiac rehabilitation, especially exercise therapy and health behavior evaluation; and the final is evidence-based medical evaluation, such as systematic reviews and meta-analyses.

show abstract

“…It should be mentioned that the current coronavirus disease 2019 (COVID-19) pandemic has been associated with an increasing burden of CVD risk factors in the population. This may result in future substantial increases in the incidence of CVD ( 11 ). Moreover, it is extremely important to control risk factors for CVD and to manage CVD effectively during the pandemic to improve the prognosis of COVID-19 patients ( 12 ).…”

Section: Introductionmentioning

confidence: 99%

Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

Surma

Sahebkar

Urbański³

et al. 2022

Front. Nutr.

View full text Add to dashboard Cite

Despite continuous advances in pharmacotherapy, atherosclerotic cardiovascular disease remains the world's leading killer. Atherosclerosis relates not only to an increased level of cholesterol, but involves the development of atherosclerotic plaques, which are formed as a result of processes including inflammation and oxidative stress. Therefore, in addition to the classical risk factors for ASCVD (such as type 2 diabetes, overweight, obesity, hypertension and metabolic syndrome), residual risk factors such as inflammation and oxidative stress should also be reduced. The most important intervention in ASCVD is prevention, which includes promoting a healthy diet based on products of natural origin. Curcumin, which is often present in the diet, has been demonstrate to confer several benefits to health. It has been shown in numerous clinical trials that curcumin exhibited anti-diabetic, lipid-lowering, antihypertensive, antioxidant and anti-inflammatory effects, as well as promoting weight loss. All this means that curcumin has a comprehensive impact on the most important risk factors of ASCVD and may be a beneficial support in the treatment of these diseases. Recently, it has also been shown that curcumin may have a beneficial effect on the course of SARS-CoV-2 infection and might be helpful in the prevention of long-COVID complications. The aim of this review is to summarize the current knowledge regarding the safety and efficacy of curcumin in the prevention and treatment of cardiometabolic diseases.

show abstract

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases

Cited by 10 publications

References 35 publications

COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study

COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021

Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

Contact Info

Product

Resources

About